Evolus | 8-K: Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance
Evolus | 8-K: Current report
Evolus | 8-K: Current report
Evolus | 8-K: Evolus Reports First Quarter 2024 Results and Provides Business Update
Evolus | DEF 14A: Definitive information statements
Evolus | DEFA14A: Others
Evolus | 8-K: Current report
Evolus | 8-K: Current report
Evolus | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Evolus | 8-K: Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
Evolus | 8-K: Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations
Evolus | 8-K: Current report
Evolus | 8-K: Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau ®
Evolus | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Evolus | 8-K: Evolus Reports Second Quarter 2023 Results and Provides Business Update
Evolus | 8-K: Current report
Evolus | 8-K: Current report
Evolus | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Evolus | 8-K: Evolus Reports First Quarter 2023 Results and Provides Business Update
Evolus | DEF 14A: Definitive proxy statements
No Data